Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study

{ 'indexed': {'date-parts': [[2022, 8, 6]], 'date-time': '2022-08-06T13:52:16Z', 'timestamp': 1659793936156}, 'reference-count': 28, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2020, 11, 2]], 'date-time': '2020-11-02T00:00:00Z', 'timestamp': 1604275200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}, { 'start': { 'date-parts': [[2020, 11, 2]], 'date-time': '2020-11-02T00:00:00Z', 'timestamp': 1604275200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 3]]}, 'DOI': '10.1007/s40121-020-00363-w', 'type': 'journal-article', 'created': {'date-parts': [[2020, 11, 2]], 'date-time': '2020-11-02T04:18:16Z', 'timestamp': 1604290696000}, 'page': '253-268', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 31, 'title': 'Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A ' 'Prospective Cohort Study', 'prefix': '10.1007', 'volume': '10', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-2459-1485', 'authenticated-orcid': False, 'given': 'Laila Carolina', 'family': 'Abu Esba', 'sequence': 'first', 'affiliation': []}, {'given': 'Rahaf Ali', 'family': 'Alqahtani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Abin', 'family': 'Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nour', 'family': 'Shamas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lolowa', 'family': 'Alswaidan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gahdah', 'family': 'Mardawi', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2020, 11, 2]]}, 'reference': [ { 'key': '363_CR1', 'unstructured': 'Times P. Managing and Treating Fever: A Guide to Nonprescription ' 'Antipyretics 2018. ' 'https://www.pharmacytimes.com/publications/issue/2018/February2018/managing-and-treating-fever-a-guide-to-nonprescription-antipyretics. ' 'Accessed 19 March 2020.'}, { 'key': '363_CR2', 'unstructured': 'Chandler M. Global ibuprofen shortage hits UK supermarkets—with shelves ' 'left empty. 2019. ' 'https://www.mirror.co.uk/news/uk-news/global-ibuprofen-shortage-hits-uk-20465178. ' 'Accessed 1 April 2020.'}, { 'key': '363_CR3', 'unstructured': 'News B. Coronavirus and ibuprofen: separating fact from fiction. 2020. ' 'https://www.bbc.com/news/51929628. Accessed 1 April 2020.'}, { 'key': '363_CR4', 'unstructured': 'Today U. Fact check: does using ibuprofen when you have coronavirus make ' 'symptoms worse? 2020. ' 'https://www.usatoday.com/story/news/factcheck/2020/03/18/fact-check-coronavirus-and-ibuprofen-do-nsaids-make-coronavirus-worse/2865866001/. ' 'Accessed 1 April 2020.'}, { 'key': '363_CR5', 'unstructured': 'News N. Concerned about taking ibuprofen for coronavirus symptoms? ' "Here's What Experts Say. 2020. " 'https://www.npr.org/sections/health-shots/2020/03/18/818026613/advice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled. ' 'Accessed 1 April 2020.'}, { 'key': '363_CR6', 'unstructured': 'Willsher K. Anti-inflammatories may aggravate Covid-19, France advises. ' '2020. ' 'https://www.theguardian.com/world/2020/mar/14/anti-inflammatory-drugs-may-aggravate-coronavirus-infection. ' 'Accessed 1 April 2020.'}, { 'issue': '4', 'key': '363_CR7', 'doi-asserted-by': 'publisher', 'first-page': 'e21', 'DOI': '10.1016/S2213-2600(20)30116-8', 'volume': '8', 'author': 'L Fang', 'year': '2020', 'unstructured': 'Fang L, Karakiulakis G, Roth M. Are patients with hypertension and ' 'diabetes mellitus at increased risk for COVID-19 infection? Lancet ' 'Respir Med. 2020;8(4):e21.', 'journal-title': 'Lancet Respir Med'}, { 'key': '363_CR8', 'unstructured': 'Agency EM. EMA gives advice on the use of non-steroidal ' 'anti-inflammatories for COVID-19. 2020. ' 'https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. ' 'Accessed 3 May 2020.'}, { 'key': '363_CR9', 'doi-asserted-by': 'publisher', 'unstructured': 'Castro VM, Ross RA, McBride SM, Perlis RH. Identifying common ' 'pharmacotherapies associated with reduced COVID-19 morbidity using ' 'electronic health records. medRxiv. 2020. ' 'https://doi.org/10.1101/2020.04.11.20061994', 'DOI': '10.1101/2020.04.11.20061994'}, { 'key': '363_CR10', 'unstructured': 'DRUG USF. FDA advises patients on use of non-steroidal anti-inflammatory ' 'drugs (NSAIDs) for COVID-19. 2020. ' 'https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19. ' 'Accessed 3 May 2020.'}, { 'key': '363_CR11', 'unstructured': 'GOV.UK. Commission on Human Medicines advice on ibuprofen and ' 'coronavirus (COVID-19). 2020. ' 'https://www.gov.uk/government/news/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19. ' 'Accessed 3 May 2020.'}, { 'key': '363_CR12', 'doi-asserted-by': 'publisher', 'unstructured': 'Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the ' 'novel coronavirus from Wuhan: an analysis based on decade-long ' 'structural studies of SARS coronavirus. J Virol. 2020;94(7):e00127–20. ' 'PMID: 31996437; PMCID: PMC7081895. https://doi.org/10.1128/JVI.00127-20', 'DOI': '10.1128/JVI.00127-20'}, { 'issue': '2', 'key': '363_CR13', 'doi-asserted-by': 'publisher', 'first-page': '97', 'DOI': '10.1159/000375362', 'volume': '131', 'author': 'W Qiao', 'year': '2015', 'unstructured': 'Qiao W, Wang C, Chen B, Zhang F, Liu Y, Lu Q, et al. Ibuprofen ' 'attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. ' 'Cardiology. 2015;131(2):97–106.', 'journal-title': 'Cardiology'}, { 'issue': '4', 'key': '363_CR14', 'doi-asserted-by': 'publisher', 'first-page': '257', 'DOI': '10.1002/pds.983', 'volume': '14', 'author': 'R Paulose-Ram', 'year': '2005', 'unstructured': 'Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of ' 'selected non-prescription and prescription non-narcotic analgesics among ' 'US adults. Pharmacoepidemiol Drug Saf. 2005;14(4):257–66.', 'journal-title': 'Pharmacoepidemiol Drug Saf.'}, { 'issue': '8', 'key': '363_CR15', 'doi-asserted-by': 'publisher', 'first-page': '687', 'DOI': '10.1002/pds.732', 'volume': '11', 'author': 'GC Curhan', 'year': '2002', 'unstructured': 'Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer ' 'MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory ' 'drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf. ' '2002;11(8):687–93.', 'journal-title': 'Pharmacoepidemiol Drug Saf'}, { 'key': '363_CR16', 'doi-asserted-by': 'publisher', 'first-page': '7027', 'DOI': '10.1038/srep07027', 'volume': '4', 'author': 'P Yang', 'year': '2014', 'unstructured': 'Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, et al. ' 'Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 ' 'virus-induced acute lung injury. Sci Rep. 2014;4:7027.', 'journal-title': 'Sci Rep'}, { 'issue': '8', 'key': '363_CR17', 'doi-asserted-by': 'publisher', 'first-page': '875', 'DOI': '10.1038/nm1267', 'volume': '11', 'author': 'K Kuba', 'year': '2005', 'unstructured': 'Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of ' 'angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung ' 'injury. Nat Med. 2005;11(8):875–9.', 'journal-title': 'Nat Med'}, { 'issue': '1', 'key': '363_CR18', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s13054-017-1823-x', 'volume': '21', 'author': 'A Khan', 'year': '2017', 'unstructured': 'Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A ' 'pilot clinical trial of recombinant human angiotensin-converting enzyme ' '2 in acute respiratory distress syndrome. Crit Care. 2017;21(1):1–9.', 'journal-title': 'Crit Care'}, { 'key': '363_CR19', 'unstructured': 'Worl Health Organization WH. R&D Blueprint and COVID-19. 2020. ' 'https://www.who.int/teams/blueprint/covid-19. Accessed 12 June 2020.'}, { 'key': '363_CR20', 'doi-asserted-by': 'publisher', 'unstructured': 'Micallef J, Soeiro T, Jonville-Béra AP. French Society of Pharmacology, ' 'Therapeutics (SFPT). Non-steroidal anti-inflammatory drugs, pharmacology ' 'and COVID-19 infection. Therapies. 2020;75(4):355-362. ' 'https://doi.org/10.1016/j.therap.2020.05.003', 'DOI': '10.1016/j.therap.2020.05.003'}, { 'issue': '3', 'key': '363_CR21', 'doi-asserted-by': 'publisher', 'first-page': '364', 'DOI': '10.1007/s11427-020-1643-8', 'volume': '63', 'author': 'Y Liu', 'year': '2020', 'unstructured': 'Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and ' 'biochemical indexes from 2019-nCoV infected patients linked to viral ' 'loads and lung injury. Sci China Life Sci. 2020;63(3):364–74.', 'journal-title': 'Sci China Life Sci'}, { 'key': '363_CR22', 'unstructured': 'ClinicalTrials.gov. LIBERATE Trial in COVID-19 (LIBERATE). 2020. ' 'https://clinicaltrials.gov/ct2/show/NCT04334629. Accessed 12 June 2020.'}, { 'key': '363_CR23', 'doi-asserted-by': 'publisher', 'first-page': '1141', 'DOI': '10.1007/s10787-020-00745-z', 'volume': '28', 'author': 'L Smart', 'year': '2020', 'unstructured': 'Smart L, Fawkes N, Goggin P, et al. A narrative review of the potential ' 'pharmacological influence and safety of ibuprofen on coronavirus disease ' '19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation ' 'and reality. Inflammopharmacol. 2020;28:1141–52. ' 'https://doi.org/10.1007/s10787-020-00745-z.', 'journal-title': 'Inflammopharmacol'}, { 'issue': '8', 'key': '363_CR24', 'first-page': '1021', 'volume': '11', 'author': 'C Amici', 'year': '2006', 'unstructured': 'Amici C, Di Coro A, Ciucci A, Chiappa L, Castilletti C, Martella V, et ' 'al. Indomethacin has a potent antiviral activity against SARS ' 'coronavirus. Antiviral Therapy. 2006;11(8):1021.', 'journal-title': 'Antiviral Therapy'}, { 'issue': '5', 'key': '363_CR25', 'doi-asserted-by': 'publisher', 'first-page': '2231', 'DOI': '10.1128/AAC.02335-12', 'volume': '57', 'author': 'N Lejal', 'year': '2013', 'unstructured': 'Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. ' 'Structure-based discovery of the novel antiviral properties of naproxen ' 'against the nucleoprotein of influenza A virus. Antimicrob Agents ' 'Chemother. 2013;57(5):2231–42.', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '6', 'key': '363_CR26', 'doi-asserted-by': 'publisher', 'first-page': '1875', 'DOI': '10.1016/j.celrep.2019.04.053', 'volume': '27', 'author': 'W Zheng', 'year': '2019', 'unstructured': 'Zheng W, Fan W, Zhang S, Jiao P, Shang Y, Cui L, et al. Naproxen ' 'exhibits broad anti-influenza virus activity in mice by impeding viral ' 'nucleoprotein nuclear export. Cell Rep. 2019;27(6):1875-855.e5.', 'journal-title': 'Cell Rep.'}, { 'key': '363_CR27', 'doi-asserted-by': 'crossref', 'unstructured': 'SafiDahaj F. RE: Response to the emerging novel coronavirus outbreak: ' 'British Medical Journal Publishing Group. 2020. ' 'https://www.bmj.com/content/368/bmj.m406/rapid-responses. Accessed 12 ' 'June 2020.', 'DOI': '10.1136/bmj.m406'}, { 'key': '363_CR28', 'unstructured': 'ClinicalTrials.gov. Efficacy of addition of naproxen in the treatment of ' 'critically ill patients hospitalized for COVID-19 infection (ENACOVID). ' '2020. https://clinicaltrials.gov/ct2/show/NCT04325633. Accessed 12 June ' '2020.'}], 'container-title': 'Infectious Diseases and Therapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'http://link.springer.com/content/pdf/10.1007/s40121-020-00363-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://link.springer.com/article/10.1007/s40121-020-00363-w/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://link.springer.com/content/pdf/10.1007/s40121-020-00363-w.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T06:39:11Z', 'timestamp': 1615531151000}, 'score': 1, 'resource': {'primary': {'URL': 'http://link.springer.com/10.1007/s40121-020-00363-w'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 11, 2]]}, 'references-count': 28, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2021, 3]]}}, 'alternative-id': ['363'], 'URL': 'http://dx.doi.org/10.1007/s40121-020-00363-w', 'relation': {}, 'ISSN': ['2193-8229', '2193-6382'], 'subject': ['Infectious Diseases', 'Microbiology (medical)'], 'container-title-short': 'Infect Dis Ther', 'published': {'date-parts': [[2020, 11, 2]]}, 'assertion': [ { 'value': '17 September 2020', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '19 October 2020', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '2 November 2020', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}]}